Driehaus Capital Management’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History
Bought
Maintained
Sold
Other funds holding DALS
Driehaus Capital Management's DALS Position: Q1 2022 in Review
Driehaus Capital Management sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q1 2022, closing a stake of 1,000,000 shares — an estimated $9.8M sold.
Driehaus Capital Management first reported a position in DALS in Q3 2021 and held it in 2 quarters. The position peaked at $9.8M in Q3 2021. 44 funds tracked by Wall St. Rank hold DALS as of Q1 2022.
- Driehaus Capital Management reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q1 2022 after selling out during the quarter.
- Driehaus Capital Management sold 1,000,000 DA32 Life Science Tech Acquisition Corp shares in Q1 2022, an estimated $9.8M.
- Driehaus Capital Management first reported a position in DA32 Life Science Tech Acquisition Corp in Q3 2021 and held it in 2 quarters.
- Driehaus Capital Management's DA32 Life Science Tech Acquisition Corp position peaked at $9.8M in Q3 2021.
- 44 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q1 2022.
Based on Driehaus Capital Management's 13F filing for Q1 2022, filed 16 May 2022.